Literature DB >> 8466217

Cutaneous T-cell recruitment in toxic epidermal necrolysis. Further evidence of CD8+ lymphocyte involvement.

O Correia1, L Delgado, J P Ramos, C Resende, J A Torrinha.   

Abstract

BACKGROUND: Toxic epidermal necrolysis (TEN) is a life-threatening disease with severe mucocutaneous shedding. Although it is widely accepted that immune mechanisms are at play, the pathophysiology of TEN is still unknown. We studied the blister fluid inflammatory cells in three drug-related cases to further define the suspected T-cell involvement in TEN. OBSERVATIONS: A peripheral blood lymphopenia, especially of CD4+ T lymphocytes, was associated with a high lymphocytic cellularity of the blister fluid. In two cases, immunophenotyping of blister fluid lymphocytes showed a predominance of the CD8 phenotype. Furthermore, using two-color flow cytometry in one patient, we could show the predominance of CD8+ CD29+ lymphocytes and CD45RA- negative cells.
CONCLUSIONS: Our findings point to a cutaneous recruitment of antigen-primed and cytotoxic T cells in TEN, further supporting the involvement of CD8+ lymphocytes in TEN pathogenesis and its immune mediation.

Entities:  

Mesh:

Year:  1993        PMID: 8466217

Source DB:  PubMed          Journal:  Arch Dermatol        ISSN: 0003-987X


  31 in total

1.  Antigenicity and immunogenicity of sulphamethoxazole: demonstration of metabolism-dependent haptenation and T-cell proliferation in vivo.

Authors:  D J Naisbitt; S F Gordon; M Pirmohamed; C Burkhart; A E Cribb; W J Pichler; B K Park
Journal:  Br J Pharmacol       Date:  2001-05       Impact factor: 8.739

Review 2.  Toxic Epidermal Necrolysis and Steven-Johnson Syndrome: A Comprehensive Review.

Authors:  Olivia A Charlton; Victoria Harris; Kevin Phan; Erin Mewton; Chris Jackson; Alan Cooper
Journal:  Adv Wound Care (New Rochelle)       Date:  2020-01-09       Impact factor: 4.730

3.  [Treatment of toxic epidermal necrolysis. Experience with 9 patients with consideration of intravenous immunoglobulin].

Authors:  P Spornraft-Ragaller; H Theilen; G S Gottschlich; M Ragaller
Journal:  Hautarzt       Date:  2006-03       Impact factor: 0.751

Review 4.  A practical guide to diagnose lesser-known immediate and delayed contrast media-induced adverse cutaneous reactions.

Authors:  Ingrid Böhm; Hans H Schild
Journal:  Eur Radiol       Date:  2006-04-20       Impact factor: 5.315

5.  Early pathological features of the cornea in toxic epidermal necrolysis.

Authors:  G P Williams; H S Mudhar; M Leyland
Journal:  Br J Ophthalmol       Date:  2007-03-14       Impact factor: 4.638

6.  Toxic epidermal necrolysis induced by a triple-drug regimen for helicobacter pylori eradication.

Authors:  Yoshihiro Matsukawa; Hiroyuki Hara; Masanori Aoki; Kentaro Inada; Motohide Kaneko; Ko Mitamura; Umihiko Sawada; Shigemasa Sawada; Takashi Horie; Toyoko Ochiai
Journal:  Clin Drug Investig       Date:  2004       Impact factor: 2.859

7.  Don't live in a town where there are no doctors: toxic epidermal necrolysis initially misdiagnosed as oral thrush.

Authors:  Abdul Majid Wani; Waleed Mohd Hussain; Mohamad Ibrahim Fatani; Khaled Shawkat Ali; Amer Mohd Khoujah; Mubeena Akhtar; Ghassan Adnan Al Maimani; Sadeya Hanif Raja; Ashraf Basraheel; Khurram Fareed
Journal:  BMJ Case Rep       Date:  2009-12-30

8.  Toxic epidermal necrolysis and Stevens-Johnson syndrome are induced by soluble Fas ligand.

Authors:  Riichiro Abe; Tadamichi Shimizu; Akihiko Shibaki; Hideki Nakamura; Hirokazu Watanabe; Hiroshi Shimizu
Journal:  Am J Pathol       Date:  2003-05       Impact factor: 4.307

9.  Ofloxacin-induced toxic epidermal necrolysis.

Authors:  Gaurang Gupta
Journal:  Indian J Crit Care Med       Date:  2014-08

Review 10.  Drug-induced severe skin reactions. Incidence, management and prevention.

Authors:  P Wolkenstein; J Revuz
Journal:  Drug Saf       Date:  1995-07       Impact factor: 5.606

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.